Strumento inattivo

Azioni Vitae Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17/10/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15/09/16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14/09/16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14/09/16

Dirigenti	Titolo	Età	Da
Ambrose Bailey PSD	President	60	25/10/16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06/06/16
John Grosso BRD	Director/Board Member	-	-

Amministratori	Titolo	Età	Da
John Grosso BRD	Director/Board Member	-	-

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-3,15%	89,69 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+3,95%	41,34 Mrd
BIOGEN INC.	-10,51%	33,72 Mrd
UCB	+60,58%	26,11 Mrd
BIOMARIN PHARMACEUTICAL INC.	-20,09%	14,63 Mrd
INCYTE CORPORATION	-8,92%	12,84 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11,46%	11,66 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,05%	11,52 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,17%	8,92 Mrd